You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019110
Jan 2020660
Feb 202017173
Mar 202044448
Apr 2020313111
May 2020525213
Jun 202034345
Jul 2020535337
Aug 202022229
Sep 202026265
Oct 202035353
Nov 202037376
Dec 2020464613
Jan 2021515122
Feb 2021505013
Mar 202136368
Apr 2021863385
May 202154548
Jun 202114014019
Jul 202134347
Aug 2021222216
Sep 2021393913
Oct 2021363611
Nov 2021474814
Dec 2021585812
Jan 202242447
Feb 2022424817
Mar 2022495211
Apr 202210010812
May 202244468
Jun 202263687
Jul 202240438
Aug 2022566231
Sep 2022505510
Oct 2022474911
Nov 2022606011
Dec 202265655
Jan 202374745
Feb 2023666612
Mar 202334343
Apr 202346479
May 2023363614
Jun 202335352
Jul 2023424311
Aug 202350513
Sep 202371719
Oct 20231971977
Nov 202342442412
Dec 202312312368
Jan 2024555539
Feb 202437374
Mar 2024343517
Apr 2024404014
May 202423249
Jun 202427308
Jul 2024484913
Aug 202433333
Sep 2024505015
Oct 202427279
Nov 2024424312
Dec 202454545
Jan 2025333310
Feb 202513513517
Mar 202512012014
Apr 20259911015
May 2025393922
Jun 202541428
Total46273867788